Value Pharmacists and Kalnins & Associates involvement in legislative efforts, with Val as point-person on a bill, or as “Mr. Pharmacy” as a subject-matter expert continues. Here we list Value Pharmacists’ projects: program and legislative participation that could also affect your state and pharmacy practice. Access to our research, or Val’s expertise, on these topics is provided to supporting members. Contact us to supplement your legislative endeavor.
2017 – 2018
Serving as Subject Matter Expert consultant (pharmacy & legislative issues).
Colorado Department of Regulatory Agencies / State Board of Pharmacy Task Force
CPESN Colorado Coordinator & Facilitator (August 2016-December 2017)
The CPESN Colorado continues to gain momentum with high performing pharmacies across the state. We distributed their participation agreements in January 2017 and, as of May 1 2017, have 25 participating high performing pharmacies enrolled. We have a strong initial group of high performing pharmacies that are ready to change the practice of pharmacy in Colorado. We are excited about our early progress. We are searching out payors and providers in the state to begin our work with. This would not be possible without the support of Ashley, Noel, and Joe. Thank you all for leading the path to our future. (Source: cpesn.com)
HB16-1324 Veterinary Access Compounded Pharmaceutical Drugs
Research and lobbyist.
∴ Led as point-person for independent, compounding pharmacies.
∴ Convened with stakeholders including state representative, independent Colorado pharmacists, Colorado Veterinary Medical Association, Department of Regulatory Agencies, Board of Pharmacy, out-of-state pharmacy.
∴ Developed strategies, tactics and tools to gain consensus of stakeholders.
∴ Crafted amendment language in alignment with points of agreement of stakeholders leading to passage.
HB16-1361 Patient Choice In Pharmacy (National application)
Research and lobbyist.
∴ Research for national application regarding patients with no choice under Medicare Part D.
∴ Developed Continuity of Care fact sheet.
∴ Lobbied committee members and provide testimony to committee.
SB16-062 Veterinary Pharmaceuticals
Research and lobbyist support.
SB16-135 Collaborative Pharmacy Practice Agreements